Related Experiment Videos
Apoptosis regulating genes in prostate cancer (review)
1Department of Surgery, School of Surgical Sciences, The Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, NE2 4HH, UK.
Oncology Reports
|May 9, 1998
Summary
Prostate cancer (prostatic adenocarcinoma) is a significant health concern. Genes regulating programmed cell death (apoptosis), like p53 and bcl-2, are key to understanding and potentially treating this disease.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostatic adenocarcinoma is a leading cause of cancer-related death in men.
- Programmed cell death (apoptosis) is crucial for maintaining prostate health.
- Hormone ablation therapy activates apoptosis in the prostate.
Purpose of the Study:
- To explore the role of apoptosis-regulating genes in prostatic adenocarcinoma.
- To identify potential therapeutic targets within these gene families.
Main Methods:
- Analysis of gene expression related to apoptosis.
- Investigation of tumor suppressor genes (e.g., p53) and proto-oncogenes (e.g., bcl-2).
- Examination of gene families involved in cell death and survival pathways.
Main Results:
- Apoptosis regulation involves key genes such as p53 and bcl-2.
- The bcl-2 gene family plays a critical role in controlling cell death and survival.
- Dysregulation of apoptosis pathways is implicated in prostate cancer progression.
Conclusions:
- Apoptosis-regulating genes are vital in the development and progression of prostate cancer.
- These genes represent promising targets for novel therapeutic strategies against prostatic adenocarcinoma.